![Malte Greune](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Malte Greune currently works at CureVac NV, as Chief Operating Officer from 2024.
Dr. Greune also formerly worked at Sanofi-Aventis Deutschland GmbH, as VP-Cartridges, Devices & Insulin Technology Group.
Dr. Greune received his Masters Business Admin degree from Clark University, doctorate degree from Universität zu Köln, and undergraduate degree from the University of Trier.
Aktiva positioner av Malte Greune
| Företag | Position | Start |
|---|---|---|
| CUREVAC | Verksamhetschef | 2021-07-01 |
Tidigare kända positioner av Malte Greune
| Företag | Position | Slut |
|---|---|---|
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Företagsledare/Principal | - |
Malte Greunes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
1
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Clark University
 Clark University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Trier
 University of Trier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
